Chemours Co (CC) officer receives two large RSU stock grants

Rhea-AI Filing Summary

Chemours Co reported that officer Michael Robert Foley acquired two grants of common stock in the form of restricted stock units. One award covers 25,013 RSUs that vest in three equal annual installments beginning on March 1, 2027, and another covers 50,027 RSUs scheduled to vest on March 1, 2029. Following these awards, Foley directly holds or is credited with 78,540 Chemours equity units, including directly owned shares, RSUs and related dividend equivalent units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foley Michael Robert

(Last) (First) (Middle)

1007 MARKET STREET

(Street)

WILMINGTON DE 19801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		A		25,013(1)	A	$0	28,513	D
Common Stock	03/02/2026		A		50,027(2)	A	$0	78,540(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock Unit ("RSU") award scheduled to vest in three equal annual installments beginning on March 1, 2027.

2. RSU award scheduled to vest on March 1, 2029.

3. Includes directly owned shares, RSUs and dividend equivalent units.

Remarks:

President, Titanium Technologies

	/s/ Eric Stein, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Chemours Co (CC) report for Michael Robert Foley?

Chemours Co reported that officer Michael Robert Foley received two equity awards of common stock in the form of restricted stock units. These awards are non-cash grants that increase his direct Chemours-related holdings and are subject to future vesting conditions over several years.

How many Chemours Co (CC) restricted stock units did Michael Robert Foley receive?

Michael Robert Foley received 25,013 restricted stock units in one grant and 50,027 restricted stock units in a second grant. Both grants are recorded at a price of $0.00 per share, reflecting that they were awards rather than open-market purchases for cash.

When do Michael Robert Foley’s Chemours (CC) restricted stock unit grants vest?

One Chemours RSU award to Michael Robert Foley is scheduled to vest in three equal annual installments beginning on March 1, 2027. The second RSU award is scheduled to vest in full on March 1, 2029. Actual receipt of shares depends on meeting these vesting dates.

What is Michael Robert Foley’s Chemours Co (CC) share balance after these awards?

After the larger RSU award, Michael Robert Foley’s reported Chemours balance is 78,540 equity units. This figure includes directly owned shares, restricted stock units, and associated dividend equivalent units, reflecting his total direct economic exposure as reported in the Form 4 filing.

Did Michael Robert Foley buy Chemours (CC) shares on the open market?

The transactions reported for Michael Robert Foley are classified as awards or other acquisitions with a per-share price of $0.00. This indicates they are equity compensation grants of restricted stock units rather than open-market purchases involving cash payments for Chemours shares.

What type of securities did Michael Robert Foley receive from Chemours Co (CC)?

Michael Robert Foley received Chemours common stock in the form of restricted stock units, which are rights to receive shares in the future upon vesting. These RSUs carry specific vesting schedules extending to 2027 and 2029 instead of being immediately unrestricted common shares.